SCHEMBL11942291

SCHEMBL11942291

Cc1cc(C(N)=O)nc(C)c1C

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
POLB P06746 2/20 0.40
DPP4 P27487 1/20 0.40
DPP8 Q6V1X1 1/20 0.40
GRM2 Q14416 8/20 0.39
SMN1; SMN2 Q16637 1/20 0.34
HTT P42858 1/20 0.34
NNMT P40261 1/20 0.34
PIM1 P11309 1/20 0.34
PIM3 Q86V86 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
CDK1 P06493 1/20 0.34
WEE1 P30291 1/20 0.34
MYT1 Q01538 1/20 0.34
CREBBP Q92793 1/20 0.34
PKMYT1 Q99640 1/20 0.34
NQO2 P16083 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12487400 0.82 LMNA (0.45) LMNAPOLBDPP4DPP8GRM2
SCHEMBL12641092 0.81 ALOX15 (0.46) LMNASMN1; SMN2
SCHEMBL16751985 0.80 LMNA (0.44) LMNAPOLBDPP4DPP8GRM2
SCHEMBL13515885 0.77 LMNA (0.41) LMNAPOLBDPP4DPP8GRM2
SCHEMBL28565443 0.73 LMNA (0.38) LMNAPOLBDPP4DPP8GRM2
SCHEMBL7718641 0.73 LMNA (0.54) LMNAPOLBGRM2HTTNNMT
SCHEMBL3999989 0.72 NOS3 (0.46) LMNAPOLBDPP4DPP8GRM2
SCHEMBL19998979 0.72 NOS3 (0.56) LMNAPOLBSMN1; SMN2HTT
SCHEMBL3120976 0.71 KDM4E (0.41) LMNAPOLBDPP4DPP8GRM2
SCHEMBL11942285 0.71 LMNA (0.42) LMNAPOLBDPP4DPP8GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116217543-A Novel CCR3 inhibitor compound and application thereof 成都康弘药业集团股份有限公司 2023-06-06 CN disclosed
CN-115768760-A Quinoxaline derivatives as anti-cancer agents 阿斯利康(瑞典)有限公司 2023-03-07 CN disclosed
CN-107912040-B Pyrrolidine amide compounds as histone demethylase inhibitors 基因泰克公司 2021-04-06 CN disclosed
US-8993772-B2 Process for the preparation of 4-amino-5-fluoro-3-halo-6-(substituted)picolinates DOW AGROSCIENCES, LLC. (US) 2015-03-31 US disclosed
US-20140206881-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-5-FLUORO-3-HALO-6-(SUBSTITUTED)PICOLINATES DOW AGROSCIENCES LLC (US) 2014-07-24 US disclosed
US-8754231-B2 Process for the preparation of 4-amino-5-fluoro-3-halo-6-(substituted)picolinates DOW AGROSCIENCES, LLC. (US) 2014-06-17 US disclosed
US-20120190859-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-5-FLUORO-3-HALO-6-(SUBSTITUTED)PICOLINATES DOW AGROSCIENCES LLC (US) 2012-07-26 US disclosed
US-7964623-B2 Tricyclic benzopyrane compound NISSAN CHEMICAL INDUSTRIES LTD. (JP) 2011-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190859-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-5-FLUORO-3-HALO-6-(SUBSTITUTED)PICOLINATES CYP4F3, CYP4F12, AFF4 LMNA 2800/4885POLB 2842/4885DPP4 57/4885
US-20140206881-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-5-FLUORO-3-HALO-6-(SUBSTITUTED)PICOLINATES CYP4F3, CYP4F12, AFF4 LMNA 2800/4885POLB 2842/4885DPP4 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.